Be The Match BioTherapies and Cryoport Join Forces to Propel Cell and Gene Therapy Advancements
In a groundbreaking move, Be The Match BioTherapies®, a pioneering organization that offers solutions for companies venturing into the development and commercialization of cell and gene therapies, has announced a strategic partnership with Cryoport, a global leader in providing innovative products and services to the rapidly evolving cell & gene therapy sector. A Partnership for […]
Exciting Advancements in Epilepsy Treatment: Neurona Therapeutics’ Breakthrough Research
Neurona Therapeutics, a pioneering biotherapeutics company, has recently unveiled groundbreaking research in the realm of regenerative cell therapy for neurological disorders. Their latest publication highlights the potential of a unique cell therapy approach to treat focal epilepsy, a condition that has long challenged the medical community due to its resistance to conventional drugs. Key Findings […]
NeuroSense’s PrimeC Shows Remarkable Impact on ALS Survival Using Innovative iPSC Model
In a groundbreaking study, NeuroSense’s PrimeC has demonstrated a significant effect on the survival rate of induced motor neurons in an innovative in vitro model. This research was conducted in collaboration with the University of Southern California’s Ichida Stem Cell Lab. The study utilized induced pluripotent stem cells (iPSCs) derived from individuals diagnosed with ALS. […]
REPROCELL and Gameto Collaborate to Enhance Assisted Fertility Using iPSCs
REPROCELL Inc. has recently announced a licensing agreement with Gameto Inc., a female-led biotech firm dedicated to transforming women’s healthcare. This agreement grants Gameto a non-exclusive right to utilize REPROCELL’s StemRNA™ Clinical Seed iPSCs. Gameto intends to leverage this clinical-grade iPSC line for the development and commercialization of its innovative program, Fertilo, which aims to […]
Stem Cells: Revolutionizing Autoimmune Treatment with Kyverna & ElevateBio
Kyverna Therapeutics, a clinical-stage cell therapy company, and ElevateBio, a technology-driven company specializing in cell and gene therapies, have announced a partnership aimed at advancing the development and manufacturing processes for Kyverna’s Ingenui-T-derived chimeric antigen receptor (CAR) T-cell therapies. The Ingenui-T platform, developed by Kyverna, is optimized for autologous CAR-T cell manufacturing for autoimmune diseases, […]
Study Published in Nature Reveals Discovery of Unique Vertebral Stem Cells with Potential to Revolutionize Patient Care
A groundbreaking study, conducted by a collaborative team from the Hospital for Special Surgery (HSS) and Weill Cornell Medicine and published in Nature, has unveiled the existence of unique vertebral stem cells in the spine. This discovery is pivotal, as it contradicts the long-held belief that all bones form through a universal ossification process. The […]
New cell therapy facility enters fight against chronic diseases
The Novo Nordisk Foundation has committed DKK 950 million (EUR 127 million) to establish the Novo Nordisk Foundation Cellerator, a world-class facility aimed at advancing cell therapies for chronic diseases like heart failure, Parkinson’s, kidney disease, type 1 diabetes, and several forms of cancer. This facility will be located at the Technical University of Denmark […]
Akari Therapeutics to Host Webinar on HSCT-TMA and the Potential of Nomacopan
Akari Therapeutics, Plc, a leading biotechnology company specializing in advanced therapies for autoimmune and inflammatory diseases, has announced its plans to host a virtual key opinion leader event on October 19, 2023, at 11:30 am ET. The primary focus of this event will be to discuss the patient care landscape for hematopoietic stem cell transplant-related […]
BD² Announces $18 Million in Grants to Understand Biology of Bipolar Disorder
BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder has recently declared its inaugural round of Discovery Research grants, amassing a total of $18 million. This significant financial commitment is aimed at fostering collaboration and directing concentrated funding towards understanding the biology of bipolar disorder. Key Highlights: Conclusion: BD²’s commitment to understanding bipolar disorder, especially through […]
Orchard Therapeutics Moves Closer to a Breakthrough Treatment for MLD
Orchard Therapeutics, a global leader in gene therapy, has recently made significant strides in the development of a treatment for metachromatic leukodystrophy (MLD). Here’s a detailed summary of the press release: Key Developments: Insights from Orchard Therapeutics: Bobby Gaspar, M.D., Ph.D., co-founder and CEO of Orchard Therapeutics, expressed the company’s commitment to addressing the urgent […]